<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sma" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sma</book-part-id>
      <title-group>
        <title>Spinal Muscular Atrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Prior</surname>
            <given-names>Thomas W</given-names>
          </name>
          <degrees>PhD, FACMG</degrees>
          <aff>Department of Pathology <break/>Ohio State University <break/>Columbus, Ohio</aff>
          <email>thomas.prior@osumc.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Finanger</surname>
            <given-names>Erika</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Neurology and Pediatrics <break/>Oregon Health and Science University<break/>Portland, Oregon</aff>
          <email>finanger@ohsu.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>2</month>
          <year>2000</year>
        </date>
        <date date-type="updated">
          <day>22</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>15</day>
          <month>7</month>
          <year>2004</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="kennedy" document-type="chapter">Spinal and Bulbar Muscular Atrophy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sma-xli" document-type="chapter">Spinal Muscular Atrophy, X-Linked Infantile</related-object>
      <abstract id="sma.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and loss of the anterior horn cells in the spinal cord (i.e., lower motor neurons) and the brain stem nuclei. The onset of weakness ranges from before birth to adolescence or young adulthood. The weakness is symmetric, proximal &#x0003e; distal, and progressive. Before the genetic basis of SMA was understood, it was classified into clinical subtypes; however, it is now apparent that the phenotype of <italic toggle="yes">SMN1-</italic>associated SMA spans a continuum without clear delineation of subtypes. Poor weight gain with growth failure, restrictive lung disease, scoliosis, joint contractures, and sleep difficulties are common complications.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SMA is established in a proband with a history of motor difficulties, evidence of motor unit disease on physical examination, and identification of biallelic pathogenic variants in <italic toggle="yes">SMN1</italic> on molecular genetic testing. Increases in <italic toggle="yes">SMN2</italic> copy number often modify the phenotype.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> When nutrition is a concern in SMA, placement of a gastrostomy tube early in the course of the disease is appropriate. Formal consultation with a pulmonologist familiar with SMA is indicated. As respiratory function deteriorates, tracheotomy or noninvasive respiratory support is offered. Surgical repair for scoliosis should be considered based on progression of the curvature, pulmonary function, and bone maturity.</p>
          <p><italic toggle="yes">Surveillance:</italic> Evaluation every six months or more frequently for weaker children to assess nutritional state, respiratory function, and orthopedic status.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>SMA is inherited in an autosomal recessive manner. Each pregnancy of a couple who have had a child with SMA has an approximately 25% chance of producing an affected child, an approximately 50% chance of producing an asymptomatic carrier, and an approximately 25% chance of producing an unaffected child who is not a carrier. These recurrence risks deviate slightly from the norm for autosomal recessive inheritance because about 2% of affected individuals have a <italic toggle="yes">de novo</italic>
<italic toggle="yes">SMN1</italic> variant on one allele; in these instances, only one parent is a carrier of an <italic toggle="yes">SMN1</italic> variant, and thus the sibs are not at increased risk for SMA. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the diagnosis of SMA has been confirmed by molecular genetic testing in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sma.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="sma.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sma.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Spinal Muscular Atrophy: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sma.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Spinal muscular atrophy 0</p></list-item><list-item><p>Spinal muscular atrophy I</p></list-item><list-item><p>Spinal muscular atrophy II</p></list-item><list-item><p>Spinal muscular atrophy III</p></list-item><list-item><p>Spinal muscular atrophy IV</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="sma.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sma.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sma.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Spinal muscular atrophy (SMA) <bold>should be suspected</bold> in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>History of motor difficulties, especially with loss of skills</p>
            </list-item>
            <list-item>
              <p>Proximal muscle weakness</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Areflexia/hyporeflexia</p>
            </list-item>
            <list-item>
              <p>Tongue fasciculations</p>
            </list-item>
            <list-item>
              <p>Evidence of motor unit disease on physical examination</p>
            </list-item>
          </list>
        </sec>
        <sec id="sma.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>A consensus document on the diagnosis of children with SMA has been developed [<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al 2007</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://journals.sagepub.com/doi/pdf/10.1177/0883073807305788">full text</ext-link>).</p>
          <p>The diagnosis of SMA <bold>is established</bold> in a proband with a history of motor difficulties, evidence of motor unit disease on physical examination, and identification of biallelic pathogenic variants in <italic toggle="yes">SMN1</italic> on molecular genetic testing (see <xref ref-type="table" rid="sma.T.molecular_genetic_testing_used_in">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Gene-targeted deletion/duplication analysis to determine the dosage of <italic toggle="yes">SMN1</italic> is performed first for the <italic toggle="yes">SMN1</italic> exon 7. If exon 7 is deleted from one copy of <italic toggle="yes">SMN1</italic>, perform sequence analysis of <italic toggle="yes">SMN1</italic>. If exon 7 is present in both copies of <italic toggle="yes">SMN1</italic>, consider other diagnoses (see <xref ref-type="sec" rid="sma.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
              <p>Because <italic toggle="yes">SMN1</italic> sequence analysis cannot determine whether a putative inactivating variant is in <italic toggle="yes">SMN1</italic> or <italic toggle="yes">SMN2</italic> (see <xref ref-type="sec" rid="sma.Molecular_Genetics">Molecular Genetics</xref>), one of the following is required to confirm that the variant is present in <italic toggle="yes">SMN1</italic>:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Establish that the inactivating variant has previously been reported in <italic toggle="yes">SMN1</italic></p>
                  <p>OR</p>
                </list-item>
                <list-item>
                  <p>Sequence a long-range PCR product or a subclone of SMN1</p>
                </list-item>
              </list>
              <p>Note: Gene-targeted deletion/duplication analysis to determine <italic toggle="yes">SMN2</italic> copy number can be performed to provide additional information for clinical correlation if the diagnosis of SMA is confirmed on molecular genetic testing (see <xref ref-type="sec" rid="sma.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> and other genes of interest (see <xref ref-type="sec" rid="sma.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm the diagnosis in an individual with features of SMA. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="sma.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Spinal Muscular Atrophy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_1">Type of Testing</th>
                  <th id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_2">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_3">Proportion of SMA Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by this Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Diagnostic, carrier, prenatal</td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">SMN1</italic>
                  </td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">2%-5%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">95%-98%&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Prognostic</td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">SMN2</italic>
                  </td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_sma.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_sma.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sma.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="sma" object-id="sma.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="sma.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="sma.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="sma.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="sma.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR and multiplex ligation-dependent probe amplification (MLPA) to detect single-exon deletions or duplications. Note that <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> are nearly identical; therefore, gene-targeted microarray cannot be used to determine <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> copy number.</p>
              </fn>
              <fn id="sma.TF.1.5">
                <label>5. </label>
                <p>Detects the 2%-5% of individuals who are compound heterozygous for an intragenic pathogenic variant and an <italic toggle="yes">SMN1</italic> deletion of at least exon 7 [<xref ref-type="bibr" rid="sma.REF.parsons.1998.1712">Parsons et al 1998</xref>, <xref ref-type="bibr" rid="sma.REF.wirth.2000.228">Wirth 2000</xref>]</p>
              </fn>
              <fn id="sma.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="sma.REF.bussaglia.1995.335">Bussaglia et al [1995]</xref>, <xref ref-type="bibr" rid="sma.REF.lefebvre.1995.155">Lefebvre et al [1995]</xref>, <xref ref-type="bibr" rid="sma.REF.parsons.1996.1727">Parsons et al [1996]</xref>, <xref ref-type="bibr" rid="sma.REF.hahnen.1997.821">Hahnen et al [1997]</xref>, <xref ref-type="bibr" rid="sma.REF.mcandrew.1997.1411">McAndrew et al [1997]</xref>, <xref ref-type="bibr" rid="sma.REF.talbot.1997.497">Talbot et al [1997]</xref>, <xref ref-type="bibr" rid="sma.REF.ogino.2002.477">Ogino &#x00026; Wilson [2002]</xref></p>
              </fn>
              <fn id="sma.TF.1.7">
                <label>7. </label>
                <p>Note: Gene-targeted deletion/duplication analysis of <italic toggle="yes">SMN2</italic> can be performed to provide additional phenotype information if the diagnosis of SMA is confirmed on molecular genetic testing. The number of copies of <italic toggle="yes">SMN2</italic> may range from zero to five. Quantitative PCR and MLPA methods are often designed to detect both <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> copy number [<xref ref-type="bibr" rid="sma.REF.anhuf.2003.74">Anhuf et al 2003</xref>, <xref ref-type="bibr" rid="sma.REF.arkblad.2006.830">Arkblad et al 2006</xref>, <xref ref-type="bibr" rid="sma.REF.scarciolla.2006.269">Scarciolla et al 2006</xref>] (see <xref ref-type="sec" rid="sma.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Testing to determine carrier status</bold> is reviewed in <xref ref-type="sec" rid="sma.Genetic_Counseling">Genetic Counseling</xref>.</p>
        </sec>
      </sec>
      <sec id="sma.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sma.Clinical_Description">
          <title>Clinical Description</title>
          <p>SMA is characterized by muscle weakness and atrophy resulting from progressive degeneration and loss of the anterior horn cells in the spinal cord (i.e., lower motor neurons) and the brain stem nuclei. The onset of weakness ranges from before birth to adolescence or young adulthood. The weakness is symmetric, proximal &#x0003e; distal, and progressive.</p>
          <sec id="sma.SMA_Phenotypes">
            <title>SMA Phenotypes</title>
            <p>Before the advent of molecular diagnosis, attempts were made to classify SMA into discrete subtypes; however, it is now apparent that the phenotype of SMA associated with <italic toggle="yes">SMN1</italic> pathogenic variants spans a broad continuum without clear delineation of subtypes. Nonetheless, the existing classification system (<xref ref-type="table" rid="sma.T.spectrum_of_sma_phenotypes">Table 2</xref>) based on age of onset and maximum function attained is useful for prognosis and management.</p>
            <table-wrap id="sma.T.spectrum_of_sma_phenotypes" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Spectrum of SMA Phenotypes</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                    <th id="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset</th>
                    <th id="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Life Span</th>
                    <th id="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Motor Milestones</th>
                    <th id="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other Findings</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <bold>SMA 0</bold>
                    </td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Prenatal</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;6 months</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">None achieved</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe neonatal hypotonia<break/>Severe weakness<break/>Early respiratory failure<break/>Facial diplegia</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <bold>SMA I</bold>
                    </td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;6 months</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Most often &#x02264;2 years, but may live longer</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sit with support only</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Mild joint contractures<break/>Normal or minimal facial weakness<break/>Variable suck &#x00026; swallow difficulties</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <bold>SMA II</bold>
                    </td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">6-18 months</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70% alive at age 25 years</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Independent sitting when placed</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Postural tremor of fingers</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <bold>SMA III</bold>
                    </td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;18 months</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Independent ambulation</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <bold>SMA IV</bold>
                    </td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Adulthood</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_sma.T.spectrum_of_sma_phenotypes_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p><bold>SMA 0 (congenital SMA)</bold> presents with severe weakness and hypotonia present at birth. There may be a history of decreased in utero movements and joint contractures. Infants with SMA type 0 have severe respiratory compromise and rarely survive past age six months [<xref ref-type="bibr" rid="sma.REF.dubowitz.1999.49">Dubowitz 1999</xref>, <xref ref-type="bibr" rid="sma.REF.macleod.1999.65">MacLeod et al 1999</xref>].</p>
            <p><bold>SMA I (severe spinal muscular atrophy, Werdnig-Hoffmann disease)</bold> manifests as severe weakness before age six months. Affected children are not able to sit without support at any time. Proximal, symmetric muscle weakness, lack of motor development, and poor muscle tone are the major clinical manifestations. Mild contractures are often noted at the knees and, rarely, at the elbows. In the neonatal period or during the first few months, those infants with the gravest prognosis have problems sucking or swallowing, leading to growth failure and recurrent aspiration. Weakness of the intercostal respiratory muscles with relative preservation of diaphragm musculature leads to characteristic &#x0201c;bell-shaped&#x0201d; chest and paradoxic respiration (abdominal breathing). The muscles of the face are relatively spared; the diaphragm is not involved until late in the course of disease. The heart is normal. Fasciculation of the tongue is seen in most but not all children. A postural tremor of the fingers is seen only occasionally.</p>
            <p>Older natural history data show 68% mortality by age two years and 82% by age four years [<xref ref-type="bibr" rid="sma.REF.zerres.1997.67">Zerres et al 1997</xref>, <xref ref-type="bibr" rid="sma.REF.munsat.1996.125">Munsat &#x00026; Davies 1996</xref>]. With improved respiratory and nutritional supportive care, survival has improved. More recent prospective studies of children with SMA type 1 have shown median survival of 24 months [<xref ref-type="bibr" rid="sma.REF.oskoui.2007.1931">Oskoui et al 2007</xref>] and median time to either death or full-time noninvasive ventilation (&#x0003e;16 hours/day) of 13.5 months [<xref ref-type="bibr" rid="sma.REF.finkel.2014.810">Finkel et al 2014</xref>].</p>
            <p><bold>SMA II (intermediate spinal muscular atrophy, Dubowitz disease)</bold> manifests as onset usually between ages six and 12 months. Although poor muscle tone may be evident at birth or within the first few months of life, individuals with SMA II may gain motor milestones slowly. The maximum motor milestone attained is the ability to sit independently when placed. Affected individuals on average lose the ability to sit independently by the mid-teens. Finger trembling and general flaccidity are common. Scoliosis is common. Progressive respiratory muscle weakness leads to restrictive lung disease that is associated with morbidity and mortality in these individuals.</p>
            <p>The life expectancy of persons with SMA II is not known with certainty. Anecdotal information shows that some live into adolescence and others as late as the third or fourth decade. A review of life expectancy of 569 individuals with SMA II and SMA III from Germany and Poland found that 68% of individuals with SMA II were alive at age 25 years [<xref ref-type="bibr" rid="sma.REF.zerres.1997.67">Zerres et al 1997</xref>].</p>
            <p><bold>SMA III (juvenile spinal muscular atrophy, Kugelberg-Welander disease)</bold> typically manifests after age 18 months. The legs are more severely affected than the arms. Individuals walk independently but may fall frequently or have trouble walking up and down stairs at age two to three years. Some individuals who are diagnosed prior to age 18 months still develop the ability to walk, although most will lose that ability with time. In a retrospective study of individuals with SMA types II and III, for those with onset before age three years the probability of walking ten years after onset was 70%, while those with onset after age three years maintained this skill longer, with nearly 60% ambulatory 40 years after onset [<xref ref-type="bibr" rid="sma.REF.zerres.1997.67">Zerres et al 1997</xref>]. This group also evaluated life expectancy of 569 individuals with SMA II and SMA III from Germany and Poland and found that life expectancy of those with SMA III was not different from that of the general population [<xref ref-type="bibr" rid="sma.REF.zerres.1997.67">Zerres et al 1997</xref>].</p>
            <p><bold>SMA IV.</bold> The onset of muscle weakness is usually in the second or third decade of life. Findings are similar to those described for SMA III [<xref ref-type="bibr" rid="sma.REF.brahe.1995.741">Brahe et al 1995</xref>, <xref ref-type="bibr" rid="sma.REF.clermont.1995.1712">Clermont et al 1995</xref>, <xref ref-type="bibr" rid="sma.REF.zerres.1997.67">Zerres et al 1997</xref>]. Life expectancy is normal.</p>
          </sec>
          <sec id="sma.Complications_of_SMA">
            <title>Complications of SMA</title>
            <p>Poor weight gain with growth failure, restrictive lung disease, scoliosis, joint contractures, and sleep difficulties are common complications of SMA.</p>
            <p><bold>Nutrition.</bold>
<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al [2007]</xref> describe the nutritional difficulties experienced by children with SMA I. Bulbar dysfunction is universal in SMA I. The bulbar dysfunction eventually becomes a serious problem for persons with SMA II and only very late in the course of disease for those with SMA III. Gastrointestinal dysmotility results in constipation, delayed gastric emptying, and potentially life-threatening gastroesophageal reflux with aspiration. Growth failure can be addressed with gastrostomy tube placement as needed.</p>
            <p><bold>Pulmonary.</bold> Individuals with SMA, particularly type I and II, show progressive respiratory decline. Respiratory failure is usually the cause of death in these subtypes. Decreased respiratory function leads to impaired cough with inadequate clearance of lower airway secretions, hypoventilation during sleep, and recurrent pneumonia.</p>
            <p><bold>Orthopedic.</bold> Scoliosis is a major problem in most persons with SMA II and in half of those with SMA III. Before age ten years, approximately 50% of affected children (especially those who are nonambulatory) develop spinal curvatures of more than 50 degrees, which require surgery. Progressive scoliosis impairs lung function and in severe cases cardiac output. Progressive scoliosis is treated with surgery when appropriate. Joint contractures and hip dislocation are also common in SMA.</p>
            <p><bold>Metabolic acidosis.</bold> An unexplained potential complication of SMA is severe metabolic acidosis with dicarboxylic aciduria and low serum carnitine concentrations during periods of intercurrent illness or fasting [<xref ref-type="bibr" rid="sma.REF.kelley.1986.734">Kelley &#x00026; Sladky 1986</xref>]. Whether these metabolic abnormalities are primary or secondary to the underlying defect in SMA is unknown. Although the etiology of these metabolic derangements remains unknown, one recent report suggests that aberrant glucose metabolism may play a role [<xref ref-type="bibr" rid="sma.REF.bowerman.2012.256">Bowerman et al 2012</xref>]. Prolonged fasting should be avoided in individuals with SMA.</p>
          </sec>
        </sec>
        <sec id="sma.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">SMN1</italic>.</bold> No correlation exists between the type of <italic toggle="yes">SMN1</italic> pathogenic variants and the severity of disease: the homozygous exon 7 deletion is observed with approximately the same frequency in all phenotypes.</p>
          <p><bold><italic toggle="yes">SMN2</italic>.</bold> The number of copies (dosage) of <italic toggle="yes">SMN2</italic> (arranged in tandem in <italic toggle="yes">cis</italic> configuration on each chromosome) ranges from zero to five (see <xref ref-type="sec" rid="sma.Molecular_Genetics">Molecular Genetics</xref>). The presence of three or more copies of <italic toggle="yes">SMN2</italic> is correlated with a milder phenotype [<xref ref-type="bibr" rid="sma.REF.mailman.2002.20">Mailman et al 2002</xref>, <xref ref-type="bibr" rid="sma.REF.prior.2004.307">Prior et al 2004</xref>, <xref ref-type="bibr" rid="sma.REF.yamashita.2004.101">Yamashita et al 2004</xref>, <xref ref-type="bibr" rid="sma.REF.solerbotija.2005.215">Soler-Botija et al 2005</xref>, <xref ref-type="bibr" rid="sma.REF.swoboda.2005.704">Swoboda et al 2005</xref>]. It was estimated, from studies performed by <xref ref-type="bibr" rid="sma.REF.zheleznyakova.2011.96">Zheleznyakova et al [2011]</xref>, that an affected child with four <italic toggle="yes">SMN2</italic> copies is at an 88% risk of having type III SMA. Small amounts of full-length transcripts generated by <italic toggle="yes">SMN2</italic> produce functional protein, and result in the milder SMA II or SMA III phenotype. Data from <xref ref-type="bibr" rid="sma.REF.mailman.2002.20">Mailman et al [2002]</xref> are summarized in <xref ref-type="table" rid="sma.T.smn2_copy_number_in_sma_i_vs_sma_i">Table 3</xref>. <xref ref-type="bibr" rid="sma.REF.prior.2004.307">Prior et al [2004]</xref> reported three asymptomatic, unrelated individuals homozygous for an <italic toggle="yes">SMN1</italic> deletion who had five copies of <italic toggle="yes">SMN2,</italic> demonstrating that expression levels consistent with five copies of <italic toggle="yes">SMN2</italic> may compensate for the lack of <italic toggle="yes">SMN1</italic> expression.</p>
          <p>In contrast to the above observations, <xref ref-type="bibr" rid="sma.REF.prior.2009.408">Prior et al [2009]</xref> described three unrelated individuals with SMA whose <italic toggle="yes">SMN2</italic> copy numbers did not correlate with the observed mild clinical phenotypes; they were found to have a single-base substitution &#x02013; c.859G&#x0003e;C (p.Gly287Arg) &#x02013; in exon 7 of <italic toggle="yes">SMN2</italic> that created a new exonic splicing enhancer (ESE) element. The new ESE increased the amount of exon 7 inclusion and full-length transcripts generated from <italic toggle="yes">SMN2</italic>, thus resulting in the less severe phenotypes.</p>
          <p><bold>Putative modifier of SMA phenotype.</bold> It was also found that in some rare families with unaffected homozygous <italic toggle="yes">SMN1</italic>-deleted females, the expression of plastin 3 (encoded by <italic toggle="yes">PLS3</italic> at chromosome locus Xq23) was higher than in their SMA-affected counterparts. <italic toggle="yes">PLS3</italic> was shown to be important for axonogenesis and therefore may act as a protective modifier [<xref ref-type="bibr" rid="sma.REF.oprea.2008.524">Oprea et al 2008</xref>]. Overexpresssion of <italic toggle="yes">PLS3</italic> has also been shown to rescue the axonal growth defects in zebrafish with reduced <italic toggle="yes">smn</italic> levels [<xref ref-type="bibr" rid="sma.REF.hao.2012.5074">Hao et al 2012</xref>].</p>
          <table-wrap id="sma.T.smn2_copy_number_in_sma_i_vs_sma_i" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p><italic toggle="yes">SMN2</italic> Copy Number in SMA I vs SMA III</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SMN2</italic> Copy Number</th>
                  <th id="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Normal</th>
                  <th id="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">In SMA I</th>
                  <th id="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">In SMA III</th>
                  <th id="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Total (SMA I + SMA III)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">14.4%</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">32%</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">7 (13.5%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0 (0%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">7 (4.9%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">51%</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">43 (82.7%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0 (0%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">43 (30.3%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4%</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2 (3.9%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">70 (77.8%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">72 (50.7%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0 (0%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">20 (22.2%)</td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">20 (14.1%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Total</bold>
                  </td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>52</bold>
                  </td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>90</bold>
                  </td>
                  <td headers="hd_h_sma.T.smn2_copy_number_in_sma_i_vs_sma_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>142</bold>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="sma.REF.mailman.2002.20">Mailman et al [2002]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="sma.Nomenclature">
          <title>Nomenclature</title>
          <p>Severe SMA or SMA I is still called Werdnig-Hoffmann disease by many [<xref ref-type="bibr" rid="sma.REF.hoffmann.1892.427">Hoffmann 1892</xref>, <xref ref-type="bibr" rid="sma.REF.werdnig.1971.276">Werdnig 1971</xref>].</p>
          <p>SMA II was called chronic SMA prior to the current classification.</p>
          <p>SMA III has had the eponym juvenile SMA or Kugelberg-Welander disease [<xref ref-type="bibr" rid="sma.REF.kugelberg.1956.500">Kugelberg &#x00026; Welander 1956</xref>].</p>
        </sec>
        <sec id="sma.Prevalence">
          <title>Prevalence</title>
          <table-wrap id="sma.T.incidence_of_sma_and_estimated_car" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Incidence of SMA and Estimated Carrier Frequency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Country</th>
                  <th id="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Incidence per 100,000 Live Births</th>
                  <th id="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Frequency</th>
                  <th id="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">England</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1/90</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="sma.REF.pearn.1978.409">Pearn [1978]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Italy</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">7.8 (all SMA)</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1/57</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_4" rowspan="2" valign="middle" align="left" colspan="1">
                    <xref ref-type="bibr" rid="sma.REF.mostacciuolo.1992.34">Mostacciuolo et al [1992]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">4.1 (SMA I)</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Germany</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1/50</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="sma.REF.thieme.1993.295">Thieme et al [1993]</xref>, <xref ref-type="bibr" rid="sma.REF.mailman.2002.20">Mailman et al [2002]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">USA&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8.3</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1/54</td>
                  <td headers="hd_h_sma.T.incidence_of_sma_and_estimated_car_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="sma.REF.sugarman.2012.27">Sugarman et al [2012]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sma.TF.4.1">
                <label>1. </label>
                <p>Included a pan ethnic population; the carrier risk for individuals who identified themselves as of northern European background (&#x02018;Caucasian&#x02019;) was 1/47, Ashkenazi Jewish 1/67, Asian 1/59, Hispanic 1/68, Asian Indian 1/52, and African American 1/72 [<xref ref-type="bibr" rid="sma.REF.sugarman.2012.27">Sugarman et al [2012]</xref>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="sma.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those described in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">SMN1</italic>.</p>
      </sec>
      <sec id="sma.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <table-wrap id="sma.T.disorders_to_consider_in_the_diffe" orientation="portrait" position="anchor">
          <label>Table 5. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of Spinal Muscular Atrophy (SMA)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1">Age of Onset</th>
                <th id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2">Disorder</th>
                <th id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3">Gene(s) or Region</th>
                <th id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4">MOI</th>
                <th id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features</th>
              </tr>
              <tr>
                <th headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5" id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping w/SMA</th>
                <th headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5" id="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing from SMA</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="9" valign="middle" align="left" scope="row" colspan="1">Congenital to &#x0003c;6 months</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="sma-xli" document-type="chapter">X-linked infantile spinal muscular atrophy</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">UBA1</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia, weakness, areflexia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple congenital contractures, fractures</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Spinal muscular atrophy and respiratory distress 1 (SMARD1)&#x000a0;<sup>1</sup> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604320">604320</ext-link>)</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">IGHMBP2</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Weakness, respiratory failure, hypo- or areflexia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Distal predominant weakness, diaphragmatic paralysis</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pws" document-type="chapter">Prader-Willi syndrome</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15q11.2-q13</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Poor respiratory effort is rare.</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter">Myotonic dystrophy type 1</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DMPK</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Absence of tongue fasciculations</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital muscular dystrophy</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Many genes</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR<break/>AD</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia, weakness</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">CNS, eye involvement</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PEX family of genes</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Loss of skills, hepatosplenomegaly</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="cms" document-type="chapter">Congenital myasthenic syndromes</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Many genes</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR<break/>AD</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Ophthalmoplegia, ptosis, intermittent respiratory failure</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="gsd2" document-type="chapter">Glycogen storage disease type II (Pompe disease)</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GAA</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Cardiomegaly</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" colspan="5" align="left" scope="col" rowspan="1">Other: congenital myopathies&#x000a0;<sup>2</sup>, metabolic/mitochondrial myopathies&#x000a0;<sup>3</sup>, peripheral neuropathies&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;6 months</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Botulism</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Proximal muscle weakness</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Prominent cranial nerve palsies, acute onset</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">Later childhood</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Guillain-Barr&#x000e9; syndrome</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" colspan="2" align="left" rowspan="1">Unknown</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Muscle weakness</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Subacute onset, sensory involvement</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Duchenne muscular dystrophy</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DMD</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Serum creatine kinase concentration is 10-20x &#x0003e; normal</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">Hexosaminidase A deficiency</related-object> (juvenile, chronic, and adult-onset variants)</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">HEXA</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Lower motor neuron disease</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Slow progression, progressive dystonia, spinocerebellar degeneration</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Fazio-Londe syndrome (see <related-object link-type="booklink" source-id="gene" document-id="riboflavin-tn" document-type="chapter">Riboflavin Transporter Deficiency Neuronopathy</related-object>)</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SLC52A2<break/>SLC52A3</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Progressive bulbar palsy</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Limited to lower cranial nerves; progresses to death in 1-5 yrs</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Monomelic amyotrophy (Hirayama disease) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/602440">602440</ext-link>)</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" colspan="2" align="left" rowspan="1">Unknown</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Muscle weakness</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Predominantly cervical; tongue may be affected (rare); other cranial nerves spared</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" colspan="5" align="left" scope="col" rowspan="1">Other: peripheral neuropathies&#x000a0;<sup>4</sup>, muscular dystrophies&#x000a0;<sup>5</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Adulthood</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">Spinal and bulbar muscular atrophy</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">AR</italic>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Proximal muscle weakness, muscle atrophy, fasciculations</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Gradually progressive, gynecomastia, testicular atrophy, reduced fertility</td>
              </tr>
              <tr>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">Amyotrophic lateral sclerosis</related-object>
                </td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Many genes</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AD<break/>AR<break/>XL</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">May begin w/pure lower motor neuron signs</td>
                <td headers="hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_1_5 hd_h_sma.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Progressive neurodegeneration; involves both upper &#x00026; lower motor neurons</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>XL = X-linked</p>
            </fn>
            <fn id="sma.TF.5.1">
              <label>1. </label>
              <p>SMARD spans a phenotypic spectrum [<xref ref-type="bibr" rid="sma.REF.guenther.2007.808">Guenther et al 2007</xref>].</p>
            </fn>
            <fn id="sma.TF.5.2">
              <label>2. </label>
              <p>Congenital myopathies (see <related-object link-type="booklink" source-id="gene" document-id="ccd" document-type="chapter">Central Core Disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cftd" document-type="chapter">Congenital Fiber Type Disproportion</related-object>, <related-object link-type="booklink" source-id="gene" document-id="nem" document-type="chapter">Nemaline Myopathy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mmd" document-type="chapter">Multiminicore Disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">X-Linked Centronuclear Myopathy</related-object>)</p>
            </fn>
            <fn id="sma.TF.5.3">
              <label>3. </label>
              <p>Metabolic/mitochondrial myopathies (see Glycogen Storage Diseases [<related-object link-type="booklink" source-id="gene" document-id="gsd1" document-type="chapter">GSD I</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd2" document-type="chapter">GSD II</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd3" document-type="chapter">GSD III</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd4" document-type="chapter">GSD IV</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd5" document-type="chapter">GSD V</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd6" document-type="chapter">GSD VI</related-object>] and <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>)</p>
            </fn>
            <fn id="sma.TF.5.4">
              <label>4. </label>
              <p>Peripheral neuropathies: see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object></p>
            </fn>
            <fn id="sma.TF.5.5">
              <label>5. </label>
              <p>Muscular dystrophies: see <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Dystrophinopathies</related-object> and <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Other disorders to consider are trauma of the cervical spinal cord, especially with breech delivery, spinal muscular atrophy with infantile cerebellar atrophy, and spinal muscular atrophy associated with brain atrophy [<xref ref-type="bibr" rid="sma.REF.chou.1990.21">Chou et al 1990</xref>, <xref ref-type="bibr" rid="sma.REF.yohannan.1991.426">Yohannan et al 1991</xref>].</p>
      </sec>
      <sec id="sma.Management">
        <title>Management</title>
        <sec id="sma.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with spinal muscular atrophy (SMA), the following evaluations are recommended.</p>
          <p>
            <bold>Nutrition/feeding assessment</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Time required to complete a feeding</p>
            </list-item>
            <list-item>
              <p>Evidence of fatigue during a feeding/meal</p>
            </list-item>
            <list-item>
              <p>Weight plotted on standard growth curves</p>
            </list-item>
          </list>
          <p>
            <bold>Respiratory function assessment</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Normal breathing pattern versus abdominal breathing pattern</p>
            </list-item>
            <list-item>
              <p>Forced vital capacity (FVC); in children older than age four years, the hand-held spirometer is accurate. When FVC is above 40%, decompensation during respiratory infection is less likely than when FVC is less than 40%.</p>
            </list-item>
          </list>
          <p><bold>Sleep assessment.</bold> Consider a sleep study if the child snores during sleep or awakes fatigued in the morning.</p>
          <p><bold>Activities of daily living.</bold> Assess equipment needed for independence, such as a power-chair and other equipment in the home to improve the quality of life for the affected individual and the caregiver.</p>
          <p><bold>Orthopedic evaluation.</bold> Evaluate for development of contractures, scoliosis, and hip dislocation.</p>
          <p><bold>Other.</bold> Consultation with a clinical geneticist and/or genetic counselor is recommended.</p>
        </sec>
        <sec id="sma.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The management of children with SMA starts with the diagnosis and classification into one of the five categories. A consensus document on the diagnosis and treatment of children with SMA has been developed [<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al 2007</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://journals.sagepub.com/doi/pdf/10.1177/0883073807305788">full text</ext-link>).</p>
          <sec id="sma.Health_Issues_Specific_to_SMA">
            <title>Health Issues Specific to SMA</title>
            <p><bold>Nutrition.</bold> Bulbar dysfunction is universal in SMA I and gastrostomy should be considered early in the course of the disease. The bulbar dysfunction eventually becomes a serious problem for persons with SMA II and only very late in the course of disease for those with SMA III. Gastrointestinal dysmotility results in constipation, delayed gastric emptying, and potentially life-threatening gastroesophageal reflux.</p>
            <p><bold>Pulmonary.</bold> Children with SMA I and II, and more rarely type III, have progressive decline in pulmonary function. Formal consultation with a pulmonologist familiar with SMA is indicated. Guidelines for assessment and intervention are published as part of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://journals.sagepub.com/doi/pdf/10.1177/0883073807305788">Consensus Statement for Standard of Care in Spinal Muscular Atrophy</ext-link> [<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al 2007</xref>].</p>
            <p>Options for management (depending on family preference) include no respiratory support, noninvasive ventilation, and tracheotomy with mechanical ventilation. These options should be discussed with the parents/care providers before respiratory failure occurs. The type of respiratory support is dependent on the individual&#x02019;s respiratory status, quality-of-life goals, and reduction in respiratory complications. Palliative care, with or without noninvasive ventilator support, is an option for the most severely affected individuals.</p>
            <p>Indications for noninvasive ventilation in SMA include hypoventilation, as demonstrated by decreased oxygen saturation by pulse oximetry or obstructive sleep apnea. Noninvasive ventilation has been shown to improve sleep breathing parameters in SMA I and II [<xref ref-type="bibr" rid="sma.REF.petrone.2007.216">Petrone et al 2007</xref>]. Noninvasive ventilation with BiPAP is commonly used in SMA as it may improve chest wall and lung development and is proposed to reduce lung infections and pulmonary comorbidity in SMA. Tracheotomy for chronic ventilation is an option that can be discussed with individuals and their families; however, it is controversial, especially in SMA I.</p>
            <p>Airway clearance can be addressed with a mechanical in-exsufflator in conjunction with suctioning and chest physiotherapy, especially in the setting of acute illness. Use of mechanical in-exsufflation in the treatment of children with neuromuscular diseases, including children with SMA, appears to reduce pulmonary complications [<xref ref-type="bibr" rid="sma.REF.chatwin.2003.502">Chatwin et al 2003</xref>, <xref ref-type="bibr" rid="sma.REF.miske.2004.1406">Miske et al 2004</xref>].</p>
            <p><bold>Scoliosis</bold> occurs frequently in individuals with SMA II. Surgical repair should be considered based on progression of the curvature, pulmonary function, and bone maturity. Use of spinal orthosis prior to surgical intervention is common; however, there is insufficient evidence that spinal orthotics alter scoliosis.</p>
            <p>Use of the vertical expandable prosthetic titanium rib (VEPTR) is a possible treatment for severe scoliosis. Chandran and colleagues described the use of VEPTR in 11 children with SMA types I and II who were followed for an average of 43 months after the initial surgery [<xref ref-type="bibr" rid="sma.REF.chandran.2011.450">Chandran et al 2011</xref>]. The average age at time of surgery was six years. No surgical complications were identified. Medical complications were seen in two affected individuals: postoperative pneumonia and anemia.</p>
            <p>A newer technology involving magnetically controlled growing rods (MAGEC rods) allows for gradual outpatient distractions controlled by an external remote device. Early case reports for this device are becoming available, although experience is not specific to SMA [<xref ref-type="bibr" rid="sma.REF.la_rosa.2017.79">La Rosa et al 2017</xref>].</p>
            <p><bold>Hip dislocation</bold> is another orthopedic concern in SMA. A retrospective review of a large series of affected individuals suggests that asymptomatic hip dislocation does not require surgery [<xref ref-type="bibr" rid="sma.REF.sporer.2003.10">Sporer &#x00026; Smith 2003</xref>].</p>
          </sec>
        </sec>
        <sec id="sma.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Comprehensive care for individuals with SMA should be provided according to the published <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://journals.sagepub.com/doi/pdf/10.1177/0883073807305788">Consensus Statement for Standard of Care in Spinal Muscular Atrophy</ext-link> [<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al 2007</xref>]. See <xref ref-type="sec" rid="sma.Treatment_of_Manifestations">Treatment of Manifestations</xref>.</p>
        </sec>
        <sec id="sma.Surveillance">
          <title>Surveillance</title>
          <p>Individuals with SMA are evaluated at least every six months; weaker children are evaluated more frequently.</p>
          <p>At each visit nutritional state, respiratory function, and orthopedic status (spine, hips, and joint range of motion) are assessed.</p>
        </sec>
        <sec id="sma.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sma.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sma.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>No therapy for SMA is currently available, however a number of compounds have been studied and newer approaches (including some directed at increasing full-length SMN protein from <italic toggle="yes">SMN2</italic> and gene replacement therapy) are being actively investigated.</p>
          <sec id="sma.SmallMolecule_Therapy_Approaches">
            <title>Small-Molecule Therapy Approaches</title>
            <p><bold>Increasing SMN protein production.</bold> Candidate molecules have been identified through cell-based high-throughput screening assays and include histone deacetylase inhibitors, aminoglycosides, and quinazolone derivatives.</p>
            <p>Histone deacetylase inhibitors (HDACIs) are small molecules that have been shown to increase SMN expression and protein levels in the cytoplasm and nuclei of cells from the SMA mouse model as well as in human fibroblasts and lymphocytes [<xref ref-type="bibr" rid="sma.REF.chang.2001.9808">Chang et al 2001</xref>, <xref ref-type="bibr" rid="sma.REF.brichta.2003.2481">Brichta et al 2003</xref>, <xref ref-type="bibr" rid="sma.REF.sumner.2003.647">Sumner et al 2003</xref>, <xref ref-type="bibr" rid="sma.REF.andreassi.2004.59">Andreassi et al 2004</xref>, <xref ref-type="bibr" rid="sma.REF.brahe.2005.256">Brahe et al 2005</xref>]. However, clinical trials of HDACIs (including phenylbutyrate and valproic acid) have shown no difference in functional outcome measures compared with placebo [<xref ref-type="bibr" rid="sma.REF.mercuri.2007.51">Mercuri et al 2007</xref>, <xref ref-type="bibr" rid="sma.REF.swoboda.2010.1605">Swoboda 2010</xref>].</p>
            <p>Another molecule, hydroxyurea, a non-HDACI, was also found to increase SMN levels in SMA cell lines, but this compound failed to show improvement in a clinical trial [<xref ref-type="bibr" rid="sma.REF.chen.2010.2190">Chen et al 2010</xref>]. Salbutamol, a &#x003b2;-adrenergic agonist, also increases SMN protein in SMA fibroblasts [<xref ref-type="bibr" rid="sma.REF.angelozzi.2008.29">Angelozzi et al 2008</xref>]. Clinical experience to date is limited to two open-label studies of salbutamol/albuterol which have reported improved motor outcomes [<xref ref-type="bibr" rid="sma.REF.kinali.2002.609">Kinali et al 2002</xref>, <xref ref-type="bibr" rid="sma.REF.pane.2008.536">Pane et al 2008</xref>]; no randomized, placebo-controlled trials have been performed to date.</p>
            <p>Quinazolone derivatives are another class of molecules identified through cell-based high-throughput screening programs. These compounds increased SMN2 promoter activity, altered SMN mRNA levels or mRNA splicing patterns, and increased SMN protein levels and nuclear gem numbers in cells derived from affected individuals [<xref ref-type="bibr" rid="sma.REF.jarecki.2005.2003">Jarecki et al 2005</xref>]. Further, delivery of these compounds to SMA mice significantly increased the mean life span (i.e., by ~21%-30%) [<xref ref-type="bibr" rid="sma.REF.butchbach.2010.835">Butchbach et al 2010</xref>].</p>
          </sec>
          <sec id="sma.Neuroprotective_and_Other_Approaches">
            <title>Neuroprotective and Other Approaches</title>
            <p>Other small molecules that have been tested but did not show proven benefit in SMA include: gabapentin [<xref ref-type="bibr" rid="sma.REF.miller.2001.127">Miller et al 2001</xref>], creatine [<xref ref-type="bibr" rid="sma.REF.wang.2007">Wang et al 2007</xref>], and riluzole [<xref ref-type="bibr" rid="sma.REF.russman.2003.1601">Russman et al 2003</xref>]. Olesoxime (TRO19622), a novel neuroprotective molecule, is currently under investigation in SMA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02628743&#x00026;Search=Search">NCT02628743</ext-link>). Finally, a novel troponin activator (CK-2127107) is currently in a Phase II trial for SMA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02644668&#x00026;Search=Search">NCT02644668</ext-link>).</p>
          </sec>
          <sec id="sma.RNABased_Therapy_Approaches">
            <title>RNA-Based Therapy Approaches</title>
            <p>Therapeutic approaches in this category aim to alter SMN2 splicing to increase the proportion of transcripts containing exon 7 and thus increase full-length SMN protein. Antisense oligonucleotides (ASOs) are single-stranded RNA molecules specifically designed to target complementary sequences in the SMN2 transcript leading to inclusion of exon 7. An antisense oligonucleotide (ASO), ASO-10-27, corrected SMN2 splicing and restored SMN expression in mice motor neurons after intracerebroventricular injection [<xref ref-type="bibr" rid="sma.REF.hua.2011.123">Hua et al 2011</xref>]. Systemic administration of ASO-10-27 robustly rescued severe SMA mice much more effectively than intracerebroventricular administration; subcutaneous injections extended the median life span 25-fold. Encouraging pre-clinical data in SMA mouse models has subsequently led to a number of current clinical trials. Phase I and II open-label studies in SMA types I-III have shown that this drug could be delivered directly to the cerebral spinal fluid via lumbar puncture in this population with acceptable tolerability (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT01494701&#x00026;Search=Search">NCT01494701</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT01703988&#x00026;Search=Search">NCT01703988</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT01839656&#x00026;Search=Search">NCT01839656</ext-link>). Thus, Ionis Pharmaceuticals has since completed enrollment for two Phase III trials of the ASO ISIS-SMNRx for the treatment of infants with SMA I (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02193074&#x00026;Search=Search">NCT02193074</ext-link>) and children with SMA II (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02292537&#x00026;Search=Search">NCT02292537</ext-link>). Results of these trials are not yet available. Finally, a trial in presymptomatic infants with genetically diagnosed SMA with this compound is also underway (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02386553&#x00026;Search=Search">NCT02386553</ext-link>).</p>
            <p>At least two other <italic toggle="yes">SNM2</italic> splicing modifiers are currently in clinical trials in SMA, including Novartis Pharmaceuticals LMI070 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02268552&#x00026;Search=Search">NCT02268552</ext-link>) and Roche RG7916 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02633709&#x00026;Search=Search">NCT02633709</ext-link>). Results of these trials are not yet available.</p>
          </sec>
          <sec id="sma.Gene_Therapy">
            <title>Gene Therapy</title>
            <p>Gene replacement therapy with viral delivery of <italic toggle="yes">SMN1</italic> is also under investigation in SMA. Foust and colleagues demonstrated that IV delivery of adeno-associated virus 9 (AAV9) carrying <italic toggle="yes">SMN1</italic> on postnatal day 1 to SMA mice led to a normal life span (&#x0003e;400 days) compared with 16 days in the untreated mice [<xref ref-type="bibr" rid="sma.REF.foust.2010.271">Foust et al 2010</xref>]. Based on these results, a Phase I trial of AAV9 containing <italic toggle="yes">SMN1</italic> (AVXS-101), delivered intravenously to infants with type I SMA, was undertaken (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=NCT02122952&#x00026;Search=Search">NCT02122952</ext-link>).</p>
            <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
          </sec>
        </sec>
      </sec>
      <sec id="sma.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sma.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Spinal muscular atrophy is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="sma.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 98% of parents of an affected child are heterozygotes (i.e., carriers of one <italic toggle="yes">SMN1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>About 2% of parents are not carriers of an <italic toggle="yes">SMN1</italic> pathogenic variant, as their affected child has a <italic toggle="yes">de novo</italic> pathogenic variant [<xref ref-type="bibr" rid="sma.REF.wirth.1997.1102">Wirth et al 1997</xref>]. The majority of <italic toggle="yes">de novo</italic> pathogenic variants are paternal in origin [<xref ref-type="bibr" rid="sma.REF.wirth.1997.1102">Wirth et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has an approximately 25% chance of being affected, an approximately 50% chance of being an asymptomatic carrier, and an approximately 25% chance of being unaffected and not a carrier.</p>
              <p>Note: Recurrence risk in sibs is the same (i.e., ~25%) if one parent of the proband has a [2+0] <italic toggle="yes">SMN1</italic> genotype (see <xref ref-type="sec" rid="sma.Carrier_Heterozygote_Detection">Carrier Detection</xref>) and the other parent has an <italic toggle="yes">SMN1</italic> exon 7 deletion [1+0] or <italic toggle="yes">SMN1</italic> intragenic variant.</p>
            </list-item>
            <list-item>
              <p>Recurrence risk in sibs of a proband with one pathogenic variant known to have been inherited from a carrier parent and one apparently <italic toggle="yes">de novo</italic> pathogenic variant (i.e., one of the parents does not have an identifiable <italic toggle="yes">SMN1</italic> pathogenic variant) is presumed to be low. However, due to the possibility that the parent in whom an <italic toggle="yes">SMN1</italic> pathogenic variant was not identified has germline mosaicism for an <italic toggle="yes">SMN1</italic> variant, these sibs should still be considered at risk for SMA [<xref ref-type="bibr" rid="sma.REF.campbell.1998.37">Campbell et al 1998</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Only individuals with the milder forms of SMA are likely to reproduce. All of their offspring are carriers. Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
            <list-item>
              <p>The unrelated reproductive partner of an individual with a mild form of SMA should be offered carrier testing. If the partner shows at least two <italic toggle="yes">SMN1</italic> copies, the partner has a one in 670 probability of being a carrier (taking into consideration the 2% frequency of two <italic toggle="yes">SMN1</italic> copies on the same chromosome and the small risk of an intragenic <italic toggle="yes">SMN1</italic> pathogenic variant). Thus, the risk to such a couple of having an affected child is one in 1340.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of an <italic toggle="yes">SMN1</italic> pathogenic variant.</p>
        </sec>
        <sec id="sma.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Molecular genetic testing may be considered to determine the carrier status of:</p>
          <list list-type="bullet">
            <list-item>
              <p>Parents of more than one child with molecularly confirmed SMA;</p>
            </list-item>
            <list-item>
              <p>Parents of a child with molecularly confirmed SMA who represents a simplex case (i.e., a single occurrence in a family);</p>
            </list-item>
            <list-item>
              <p>Parents of a child with suspected but not molecularly confirmed SMA;</p>
            </list-item>
            <list-item>
              <p>Persons not known to have a family history of SMA, who are a reproductive partner of known carrier.</p>
              <p>Note: In the general population most people have one copy of <italic toggle="yes">SMN1</italic> on each chromosome ([1+1] configuration); however, about 5%-8% of the population have two copies of <italic toggle="yes">SMN1</italic> on a single chromosome and a deletion on the other chromosome, known as a [2+0] configuration. Individuals with a [2+0] <italic toggle="yes">SMN1</italic> configuration will have a false negative carrier screening result.</p>
            </list-item>
          </list>
          <p><bold>Interpretation of the results of carrier testing.</bold> Approximately 6% of parents of a child with SMA resulting from a homozygous <italic toggle="yes">SMN1</italic> deletion have normal results of <italic toggle="yes">SMN1</italic> dosage testing for the following two reasons:</p>
          <list list-type="bullet">
            <list-item>
              <p>About 4% of carriers have two copies of <italic toggle="yes">SMN1</italic> on a single chromosome [<xref ref-type="bibr" rid="sma.REF.mcandrew.1997.1411">McAndrew et al 1997</xref>]. These carrier individuals with two copies of <italic toggle="yes">SMN1</italic> on one chromosome (a [2+0] genotype) are misdiagnosed as non-carriers by the <italic toggle="yes">SMN1</italic> dosage test (i.e., a false negative test result).</p>
              <p>A specific haplotype block is associated with a [2+0] genotype in the Ashkenazi Jewish population [<xref ref-type="bibr" rid="sma.REF.luo.2014.149">Luo et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">De novo</italic> deletion of exon 7 of one <italic toggle="yes">SMN1</italic> allele occurs in 2% of individuals with SMA; thus, only one parent is a carrier.</p>
            </list-item>
            <list-item>
              <p>In the United States pan ethnic population, the calculated a priori carrier frequency is 1/54 with a detection rate of 91.2%. Therefore, an individual from this pan ethnic population with normal <italic toggle="yes">SMN1</italic> dosage testing would have a ~1/500 residual risk of being a carrier [<xref ref-type="bibr" rid="sma.REF.sugarman.2012.27">Sugarman et al 2012</xref>].</p>
            </list-item>
          </list>
          <sec id="sma.Determining_Carrier_Status">
            <title>Determining Carrier Status</title>
            <p><bold>In parents of</bold>
<bold>more than one child with molecularly confirmed SMA.</bold> If the children are confirmed to have exon 7 deleted from both copies of <italic toggle="yes">SMN1,</italic> perform <italic toggle="yes">SMN1</italic> targeted deletion/duplication analysis on both parents:</p>
            <list list-type="bullet">
              <list-item>
                <p>When exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in both parents, their carrier status is confirmed.</p>
              </list-item>
              <list-item>
                <p>When exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in only one parent, the parent in whom the exon 7 <italic toggle="yes">SMN1</italic> deletion was not identified is likely to have one chromosome 5 with two copies of <italic toggle="yes">SMN1</italic> and one chromosome 5 with no copies of <italic toggle="yes">SMN1</italic> (i.e., an <italic toggle="yes">SMN1</italic> [2+0] genotype).</p>
              </list-item>
            </list>
            <p>If the children are confirmed to be compound heterozygotes for an exon 7 deletion on one copy of <italic toggle="yes">SMN1</italic> and an intragenic variant on the other copy of <italic toggle="yes">SMN1</italic>, perform <italic toggle="yes">SMN1</italic> dosage analysis on both parents:</p>
            <list list-type="bullet">
              <list-item>
                <p>One parent is expected to have the <italic toggle="yes">SMN1</italic> deletion.</p>
              </list-item>
              <list-item>
                <p>Perform molecular genetic testing for the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant identified in the child on the parent in whom the exon 7 deletion was not detected.</p>
              </list-item>
              <list-item>
                <p>If the intragenic <italic toggle="yes">SMN1</italic> variant identified in the child is not identified in leukocyte DNA from the parent, it is likely that the parent has germline mosaicism for the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant.</p>
              </list-item>
            </list>
            <p><bold>In parents of a child with molecularly confirmed SMA who represents a simplex case (i.e., a single occurrence in a family).</bold> If the child is confirmed to have exon 7 deleted from both copies of <italic toggle="yes">SMN1</italic>, first perform <italic toggle="yes">SMN1</italic> dosage analysis on both parents:</p>
            <list list-type="bullet">
              <list-item>
                <p>If exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in both parents, carrier status is confirmed in the parents.</p>
              </list-item>
              <list-item>
                <p>If exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in only one parent, possible explanations include:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>The parent in whom the exon 7 <italic toggle="yes">SMN1</italic> deletion was not identified may have one chromosome 5 with two copies of <italic toggle="yes">SMN1</italic> and one chromosome 5 with no copies of <italic toggle="yes">SMN1</italic> (i.e., a [2+0] <italic toggle="yes">SMN1</italic> genotype).</p>
                    <p>Note: (1) Testing additional family members of the parent with the [2+0] <italic toggle="yes">SMN1</italic> genotype may be informative: usually one of his/her parents has a deletion (1/0 <italic toggle="yes">SMN1</italic> genotype) and the other parent has three or more <italic toggle="yes">SMN1</italic> copies (2/1 <italic toggle="yes">SMN1</italic> genotype). (2) If the parent of a child with SMA who has one chromosome 5 with two copies of <italic toggle="yes">SMN1</italic> and one chromosome 5 with no copies of <italic toggle="yes">SMN1</italic> (i.e., a [2+0] <italic toggle="yes">SMN1</italic> genotype) has children with a known carrier, the children are at 25% risk to have SMA as the result of inheriting the chromosome 5 with no copies of <italic toggle="yes">SMN1</italic> from this parent and the chromosome 5 with the <italic toggle="yes">SMN1</italic> exon 7 deletion or <italic toggle="yes">SMN1</italic> intragenic pathogenic variant from the carrier parent.</p>
                  </list-item>
                  <list-item>
                    <p>The child may have a <italic toggle="yes">de novo</italic> deletion of exon 7.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p>If the child is confirmed to have exon 7 deleted from one copy of <italic toggle="yes">SMN1</italic> and an intragenic pathogenic variant in the other copy of <italic toggle="yes">SMN1</italic>, first perform <italic toggle="yes">SMN1</italic> dosage analysis on both parents:</p>
            <list list-type="bullet">
              <list-item>
                <p>Typically one parent is found to have the <italic toggle="yes">SMN1</italic> deletion.</p>
              </list-item>
              <list-item>
                <p>Molecular genetic testing for the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant identified in the child should be performed on the parent in whom the exon 7 deletion was not detected.</p>
              </list-item>
              <list-item>
                <p>If the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant is identified in the parent, carrier status is confirmed in that parent.</p>
              </list-item>
              <list-item>
                <p>If the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant identified in the child is not identified in the parent, possible explanations include:</p>
                <list list-type="bullet">
                  <list-item>
                    <p><italic toggle="yes">De novo</italic> intragenic <italic toggle="yes">SMN1</italic> pathogenic variant in the child;</p>
                  </list-item>
                  <list-item>
                    <p>Germline mosaicism for the intragenic <italic toggle="yes">SMN1</italic> pathogenic variant in the parent.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>In parents of a deceased child with suspected but not molecularly confirmed SMA.</bold> As a first step, attempt to test any available tissue samples, such as muscle biopsies (even if imbedded in paraffin) and bloodspots from newborn screening, as these samples can <bold>often</bold> provide enough DNA for molecular genetic testing.</p>
            <p>If DNA is not available, perform <italic toggle="yes">SMN1</italic> dosage analysis on both parents:</p>
            <list list-type="bullet">
              <list-item>
                <p>If exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in both parents, carrier status is confirmed in the parents.</p>
              </list-item>
              <list-item>
                <p>If exon 7 is found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in only one parent, sequence analysis of <italic toggle="yes">SMN1</italic> should be considered in the parent in whom the deletion was not detected.</p>
              </list-item>
              <list-item>
                <p>If exon 7 is not found to be deleted from one copy of <italic toggle="yes">SMN1</italic> in either parent, alternate diagnoses should be considered.</p>
              </list-item>
            </list>
            <p><bold>Carrier testing for persons not known to have a family history of SMA</bold> (e.g., for the reproductive partner of a carrier) requires <italic toggle="yes">SMN1</italic> dosage analysis. If such an individual is found to have at least two <italic toggle="yes">SMN1</italic> copies, the probability of being a carrier is approximately 1/670 (taking into consideration the 2% frequency of two <italic toggle="yes">SMN1</italic> copies on the same chromosome and the small risk of being a carrier for an intragenic <italic toggle="yes">SMN1</italic> pathogenic variant).</p>
          </sec>
        </sec>
        <sec id="sma.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sma.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>High-risk pregnancy.</bold> Once the <italic toggle="yes">SMN1</italic> pathogenic variants in both parents are known or linkage has been established in the family, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for SMA [<xref ref-type="bibr" rid="sma.REF.moutou.2003.685">Moutou et al 2003</xref>, <xref ref-type="bibr" rid="sma.REF.malcov.2004.199">Malcov et al 2004</xref>] are possible.</p>
          <p>The situations in which prenatal testing is likely to occur and the issues in test result interpretation are the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>The couple are the parents of a child with SMA.</bold> It would be predicted that a fetus with the same genotype (i.e., molecular genetic test result) as a previously affected sib would have similar clinical findings.</p>
            </list-item>
            <list-item>
              <p><bold>One or both parents are heterozygous for an <italic toggle="yes">SMN1</italic> pathogenic variant detected during testing of relatives and their partners.</bold> In this instance:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Interpretation of test results and prediction of clinical findings in an affected child may be difficult and should be done in the context of formal genetic counseling.</p>
                </list-item>
                <list-item>
                  <p>An <italic toggle="yes">SMN2</italic> copy number determination on the prenatal specimen may help to better predict the phenotype of the affected child.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Low-risk pregnancy.</bold> For the fetus with reduced fetal movement at no known increased risk for SMA, SMA needs to be considered, as do the disorders discussed in the <xref ref-type="sec" rid="sma.Differential_Diagnosis">Differential Diagnosis</xref> [<xref ref-type="bibr" rid="sma.REF.macleod.1999.65">MacLeod et al 1999</xref>].</p>
        </sec>
      </sec>
      <sec id="sma.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sma.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="sma.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">SMN1</italic> produces a full-length survival motor neuron protein necessary for lower motor neuron function [<xref ref-type="bibr" rid="sma.REF.lefebvre.1995.155">Lefebvre et al 1995</xref>]. <italic toggle="yes">SMN2</italic> predominantly produces a survival motor neuron protein that is lacking in exon 7, a less stable protein. SMA is caused by loss of <italic toggle="yes">SMN1</italic> because <italic toggle="yes">SMN2</italic> cannot fully compensate for loss of <italic toggle="yes">SMN1-</italic>produced protein. However, when the <italic toggle="yes">SMN2</italic> (dosage) copy number is increased, the small amount of full-length transcript generated by <italic toggle="yes">SMN2</italic> is often able to produce a milder type II or type III phenotype.</p>
          <sec id="sma.SMN1_and_SMN2">
            <title><italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic></title>
            <p><bold>Gene structure.</bold> The SMN region on chromosome 5q12.2-q13.3 is unusually complex, with repetitive sequences, pseudogenes, retrotransposable elements, deletions, and inverted duplications [<xref ref-type="bibr" rid="sma.REF.biros.1999.1">Biros &#x00026; Forrest 1999</xref>]. Unaffected individuals have two genes encoding SMN protein that are arranged in tandem on each chromosome: <italic toggle="yes">SMN1</italic> (telomeric copy, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000344.3">NM_000344.3</ext-link>) and <italic toggle="yes">SMN2</italic> (centromeric copy, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_017411.3">NM_017411.3</ext-link>).</p>
            <list list-type="bullet">
              <list-item>
                <p>Other terms that have been used to identify <italic toggle="yes">SMN1</italic>: telSMN, SMNt (t for telomeric), SMNT</p>
              </list-item>
              <list-item>
                <p>Other terms that have been used to identify <italic toggle="yes">SMN2</italic>: cenSMN, SMNc (c for centromeric), BCD541, SMNC</p>
              </list-item>
            </list>
            <p><italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> each comprise nine exons and differ only in eight nucleotides (5 intronic; 3 exonic, 1 each located within exons 6, 7, and 8) [<xref ref-type="bibr" rid="sma.REF.biros.1999.1">Biros &#x00026; Forrest 1999</xref>]. <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic> share more than 99% nucleotide identity, and both are capable of encoding a 294-amino acid RNA-binding protein, SMN, which is required for efficient assembly of snRNP complexes.</p>
            <p>For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sma" object-id="sma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Loss of <italic toggle="yes">SMN1</italic> causes SMA. Individuals with SMA are either homozygous for a deletion of at least exon 7 of <italic toggle="yes">SMN1</italic> or are compound heterozygous for such a deletion along with an intragenic <italic toggle="yes">SMN1</italic> inactivating pathogenic variant. Exon 7 of <italic toggle="yes">SMN1</italic> is undetectable in more than 95% of individuals with SMA irrespective of the clinical subtype of SMA, either as a result of homozygous deletions or gene conversion of <italic toggle="yes">SMN1</italic> sequence into <italic toggle="yes">SMN2</italic> sequences (possible because of their high nucleotide identity).</p>
            <table-wrap id="sma.T.smn2_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p><italic toggle="yes">SMN2</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.859G&#x0003e;C</td>
                    <td headers="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly287Arg</td>
                    <td headers="hd_h_sma.T.smn2_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_017411.3">NM_017411.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_059107.1">NP_059107.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> SMN is localized to novel nuclear structures called 'gems;' gems appear similar to (and possibly interact with) coiled bodies, which are thought to play a role in the processing and metabolism of small nuclear RNAs [<xref ref-type="bibr" rid="sma.REF.liu.1996.3555">Liu &#x00026; Dreyfuss 1996</xref>]. Evidence supports a role for SMN protein in snRNP (small nuclear ribonuclear protein) biogenesis and function [<xref ref-type="bibr" rid="sma.REF.fischer.1997.1023">Fischer et al 1997</xref>, <xref ref-type="bibr" rid="sma.REF.liu.1997.1013">Liu et al 1997</xref>, <xref ref-type="bibr" rid="sma.REF.pellizzoni.1998.615">Pellizzoni et al 1998</xref>]. SnRNPs and possibly other splicing components require regeneration from inactivated to activated functional forms. SMN is required for reassembly and regeneration of these splicing components [<xref ref-type="bibr" rid="sma.REF.pellizzoni.1998.615">Pellizzoni et al 1998</xref>]. SMN accomplishes this in a modular way, bringing together several RNA-binding proteins with several RNAs, facilitating the assembly of specific proteins on the target RNAs.</p>
            <p>The SMN protein has also been reported to influence other cellular activities such as apoptosis and translational regulation [<xref ref-type="bibr" rid="sma.REF.strasswimmer.1999.1219">Strasswimmer et al 1999</xref>, <xref ref-type="bibr" rid="sma.REF.lefebvre.2002.1017">Lefebvre et al 2002</xref>, <xref ref-type="bibr" rid="sma.REF.vyas.2002.2751">Vyas et al 2002</xref>]. SMN modulates apoptosis by blocking the activation of several caspases and other key regulators of cell survival [<xref ref-type="bibr" rid="sma.REF.anderton.2013.821">Anderton et al 2013</xref>]. SMN regulates translation by associating with polysomes, resulting in repression of translation [<xref ref-type="bibr" rid="sma.REF.sanchez.2013.668">Sanchez et al 2013</xref>].</p>
            <p><bold>Abnormal gene product.</bold> SMA may be the result of a genetic defect in the biogenesis and trafficking of the spliceosomal snRNP complexes. Mutated SMN, such as that found in individuals with SMA, lacks the splicing-regeneration activity of wild-type SMN. Reduced SMN lowers the capacity of cells to assemble the snRNPs, which leads to altered levels of spliceosomal components and defects in splicing, and impaired capacity to produce specific mRNAs and their encoded proteins that are necessary for cellular growth and function. It remains unclear how a defect of splicing results in a motor neuron-specific disorder [<xref ref-type="bibr" rid="sma.REF.workman.2012.93">Workman et al 2012</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="sma.References">
        <title>References</title>
        <sec id="sma.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="sma.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="sma.REF.wang.2007">
              <mixed-citation publication-type="web">Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO, Trela A; Participants of the International Conference on SMA Standard of Care. Consensus statement for standard of care in spinal muscular atrophy. American Society of Gene and Cell Therapy 19th Annual Meeting. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://journals.sagepub.com/doi/pdf/10.1177/0883073807305788">online</ext-link>. 2007. Accessed 12-20-2016.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sma.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sma.Literature_Cited.reflist0">
            <ref id="sma.REF.anderton.2013.821">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderton</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloni</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastaglia</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron.</article-title>
                <source>Mol Neurobiol</source>
                <volume>47</volume>
                <fpage>821</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">23315303</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.andreassi.2004.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andreassi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitali</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vincenzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boninsegna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahe</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>12</volume>
                <fpage>59</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">14560316</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.angelozzi.2008.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angelozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahe</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.</article-title>
                <source>J Med Genet.</source>
                <year>2008</year>
                <volume>45</volume>
                <fpage>29</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">17932121</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.anhuf.2003.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anhuf</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggermann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Determination of SMN1 and SMN2 copy number using TaqMan technology.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>74</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12815596</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.arkblad.2006.830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arkblad</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimber</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordling</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2006</year>
                <volume>16</volume>
                <fpage>830</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17049859</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.biros.1999.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biros</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Spinal muscular atrophy: untangling the knot?</article-title>
                <source>J Med Genet.</source>
                <volume>36</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9950358</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.bowerman.2012.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bowerman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalski</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeks</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beauvais</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woulfe</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Screaton</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kothary</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Glucose metabolism and pancreatic defects in spinal muscular atrophy.</article-title>
                <source>Ann Neurol.</source>
                <year>2012</year>
                <volume>72</volume>
                <fpage>256</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">22926856</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.brahe.1995.741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brahe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zappata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonali</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy.</article-title>
                <source>Lancet</source>
                <volume>346</volume>
                <fpage>741</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">7658877</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.brahe.2005.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brahe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitali</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moscato</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>13</volume>
                <fpage>256</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15523494</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.brichta.2003.2481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brichta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebzehnrubl</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raschke</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumcke</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyupoglu</surname>
                    <given-names>IY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>2481</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12915451</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.bussaglia.1995.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bussaglia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clermont</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tizzano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rglen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiget</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients.</article-title>
                <source>Nat Genet</source>
                <volume>11</volume>
                <fpage>335</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7581461</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.butchbach.2010.835">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Butchbach</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>FF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Rhoades</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marston</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCrone</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinnott</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorson</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <article-title>Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>2010</year>
                <volume>391</volume>
                <fpage>835</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">19945425</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.campbell.1998.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>KE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>37</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">9634516</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.chandran.2011.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarthy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noonan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemeth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiliani</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Early treatment of scoliosis with growing rods in children with severe spinal muscular atrophy: a preliminary report.</article-title>
                <source>J Pediatr Orthop.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>450</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21572284</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.chang.2001.9808">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh-Li</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jong</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Treatment of spinal muscular atrophy by sodium butyrate.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2001</year>
                <volume>98</volume>
                <fpage>9808</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">11504946</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.chatwin.2003.502">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chatwin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickol</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polkey</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonds</surname>
                    <given-names>AK</given-names>
                  </name>
                </person-group>
                <article-title>Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness.</article-title>
                <source>Eur Respir J.</source>
                <year>2003</year>
                <volume>21</volume>
                <fpage>502</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12662009</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.chen.2010.2190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mai</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>YB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jong</surname>
                    <given-names>YJ</given-names>
                  </name>
                </person-group>
                <article-title>Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>75</volume>
                <fpage>2190</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21172842</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.chou.1990.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chun</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laxova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuffli</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sufit</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krassikot</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA).</article-title>
                <source>Clin Neuropathol</source>
                <volume>9</volume>
                <fpage>21</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">2407400</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.clermont.1995.1712">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clermont</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rglen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>SMN gene deletions in adult-onset spinal muscular atrophy.</article-title>
                <source>Lancet.</source>
                <volume>346</volume>
                <fpage>1712</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8551862</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.dubowitz.1999.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V.</given-names>
                  </name>
                </person-group>
                <article-title>Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>1999</year>
                <volume>3</volume>
                <fpage>49</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">10700538</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.finkel.2014.810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finkel</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDermott</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darras</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sproule</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foley</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martens</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oskoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glanzman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flickinger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunaway</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hagen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quigley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marra</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Observational study of spinal muscular atrophy type I and implications for clinical trials.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>810</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25080519</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.fischer.1997.1023">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreyfuss</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.</article-title>
                <source>Cell</source>
                <volume>90</volume>
                <fpage>1023</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9323130</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.foust.2010.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Foust</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGovern</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevan</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haidet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rich</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>BK</given-names>
                  </name>
                </person-group>
                <article-title>Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.</article-title>
                <source>Nat Biotechnol.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>271</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20190738</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.guenther.2007.808">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guenther</surname>
                    <given-names>UP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlicke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutrannoy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Au</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis.</article-title>
                <source>Hum Mutat.</source>
                <volume>28</volume>
                <fpage>808</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">17431882</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.hahnen.1997.821">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schonling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raschke</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA).</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>821</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9158159</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.hao.2012.5074">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hao</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beattie</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <article-title>Survival motor neuron affects plastin 3 protein levels leading to motor defects.</article-title>
                <source>J Neurosci.</source>
                <year>2012</year>
                <volume>32</volume>
                <fpage>5074</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">22496553</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.hoffmann.1892.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Familial spinal muscular atrophy in infancy (article in German).</article-title>
                <source>Dtsch Z Nervenheilkd.</source>
                <year>1892</year>
                <volume>3</volume>
                <fpage>427</fpage>
                <lpage>70</lpage>
              </element-citation>
            </ref>
            <ref id="sma.REF.hua.2011.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hua</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hung</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horev</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krainer</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>2010. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.</article-title>
                <source>Nature.</source>
                <year>2011</year>
                <volume>478</volume>
                <fpage>123</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21979052</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.jarecki.2005.2003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jarecki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coovert</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitney</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stack</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollok</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <article-title>Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2005</year>
                <volume>14</volume>
                <fpage>2003</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">15944201</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.kelley.1986.734">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sladky</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Dicarboxylic aciduria in an infant with spinal muscular atrophy.</article-title>
                <source>Ann Neurol</source>
                <volume>20</volume>
                <fpage>734</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">3813501</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.kinali.2002.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kinali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Biasia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karatza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banks</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Pilot trial of albuterol in spinal muscular atrophy.</article-title>
                <source>Neurology.</source>
                <volume>59</volume>
                <fpage>609</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12196659</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.kugelberg.1956.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kugelberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welander</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Heredofamilial juvenile muscular atrophy simulating muscular dystrophy.</article-title>
                <source>AMA Arch Neurol Psychiatry.</source>
                <year>1956</year>
                <volume>75</volume>
                <fpage>500</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">13312732</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.la_rosa.2017.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Rosa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oggiano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruzzini</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Magnetically controlled growing rods for the management of early-onset scoliosis: a preliminary report.</article-title>
                <source>J Pediatr Orthop.</source>
                <year>2017</year>
                <volume>37</volume>
                <fpage>79</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">26192879</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.lefebvre.1995.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rglen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reboullet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clermont</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viollet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benichou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millasseau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Paslier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fr&#x000e9;zal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Identification and characterization of a spinal muscular atrophy-determining gene</article-title>
                <source>Cell</source>
                <volume>80</volume>
                <fpage>155</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">7813012</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.lefebvre.2002.1017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viollet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrandy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>1017</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">11978761</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.liu.1996.3555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreyfuss</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A novel nuclear structure containing the survival of motor neurons protein.</article-title>
                <source>EMBO J</source>
                <volume>15</volume>
                <fpage>3555</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">8670859</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.liu.1997.1013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreyfuss</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.</article-title>
                <source>Cell</source>
                <volume>90</volume>
                <fpage>1013</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">9323129</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.luo.2014.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peter</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eversley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornreich</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edelmann</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy.</article-title>
                <source>Genet Med.</source>
                <year>2014</year>
                <volume>16</volume>
                <fpage>149</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">23788250</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.macleod.1999.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunt</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal onset spinal muscular atrophy.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>1999</year>
                <volume>3</volume>
                <fpage>65</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">10700541</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.mailman.2002.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mailman</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinz</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papp</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snyder</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedra</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.</article-title>
                <source>Genet Med</source>
                <volume>4</volume>
                <fpage>20</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11839954</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.malcov.2004.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malcov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei-Raz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yosef</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lessing</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shomrat</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orr-Urtreger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaron</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Multiplex nested PCR for preimplantation genetic diagnosis of spinal muscular atrophy.</article-title>
                <source>Fetal Diagn Ther</source>
                <volume>19</volume>
                <fpage>199</fpage>
                <lpage>206</lpage>
                <pub-id pub-id-type="pmid">14764971</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.mcandrew.1997.1411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McAndrew</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochette</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.</article-title>
                <source>Am J Hum Genet</source>
                <volume>60</volume>
                <fpage>1411</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9199562</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.mercuri.2007.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berardinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boffi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colitto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mongini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelliccioni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vita</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahe</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy.</article-title>
                <source>Neurology.</source>
                <volume>68</volume>
                <fpage>51</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17082463</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.miller.2001.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dronsky</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelinas</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kissel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendoza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samaha</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A placebo-controlled trial of gabapentin in spinal muscular atrophy.</article-title>
                <source>J Neurol Sci</source>
                <volume>191</volume>
                <fpage>127</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11677003</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.miske.2004.1406">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miske</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickey</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolb</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panitch</surname>
                    <given-names>HB</given-names>
                  </name>
                </person-group>
                <article-title>Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough.</article-title>
                <source>Chest.</source>
                <year>2004</year>
                <volume>125</volume>
                <fpage>1406</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">15078753</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.mostacciuolo.1992.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mostacciuolo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danieli</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Epidemiology of spinal muscular atrophies in a sample of the Italian population.</article-title>
                <source>Neuroepidemiology</source>
                <volume>11</volume>
                <fpage>34</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1608493</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.moutou.2003.685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moutou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardes</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viville</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Duplex PCR for preimplantation genetic diagnosis (PGD) of spinal muscular atrophy.</article-title>
                <source>Prenat Diagn</source>
                <volume>23</volume>
                <fpage>685</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12913876</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.munsat.1996.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munsat</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Spinal muscular atrophy. 32nd ENMC International Workshop. Naarden, The Netherlands, 10-12 March 1995.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>1996</year>
                <volume>6</volume>
                <fpage>125</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8664564</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.ogino.2002.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ogino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>RB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Genetic testing and risk assessment for spinal muscular atrophy (SMA).</article-title>
                <source>Hum Genet</source>
                <volume>111</volume>
                <fpage>477</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">12436240</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.oprea.2008.524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oprea</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krober</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mcwhorter</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossoll</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawczak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassell</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beattie</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Plastin 3 is a protective modifier os autosomal recessive spinal muscular atrophy.</article-title>
                <source>Science</source>
                <volume>320</volume>
                <fpage>524</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18440926</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.oskoui.2007.1931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oskoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garland</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hagen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The changing natural history of spinal muscular atrophy type 1.</article-title>
                <source>Neurology.</source>
                <volume>69</volume>
                <fpage>1931</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17998484</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.pane.2008.536">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staccioli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelliccioni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzone</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuttini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alfieri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Daily salbutamol in young patients with SMA type II.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>18</volume>
                <fpage>536</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">18579379</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.parsons.1998.1712">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McAndrew</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>63</volume>
                <fpage>1712</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">9837824</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.parsons.1996.1727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McAndrew</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monani</surname>
                    <given-names>UR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>5</volume>
                <fpage>1727</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">8922999</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.pearn.1978.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearn</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1978</year>
                <article-title>Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.</article-title>
                <source>J Med Genet</source>
                <volume>15</volume>
                <fpage>409</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">745211</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.pellizzoni.1998.615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pellizzoni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kataoka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charroux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreyfuss</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing.</article-title>
                <source>Cell</source>
                <volume>95</volume>
                <fpage>615</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">9845364</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.petrone.2007.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testa</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petreschi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cutrera</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Noninvasive ventilation in children with spinal muscular atrophy types 1 and 2.</article-title>
                <source>Am J Phys Med Rehabil.</source>
                <year>2007</year>
                <volume>86</volume>
                <fpage>216</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17314706</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.prior.2009.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krainer</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hua</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snyder</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bridgeman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kissel</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>A positive modifier of spinal muscular atrophy in the SMN2 gene.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2009</year>
                <volume>85</volume>
                <fpage>408</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">19716110</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.prior.2004.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejmanowski</surname>
                    <given-names>AQ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.</article-title>
                <source>Am J Med Genet A</source>
                <volume>130A</volume>
                <fpage>307</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15378550</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.russman.2003.1601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Russman</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samaha</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A phase 1 trial of riluzole in spinal muscular atrophy.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>1601</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14623733</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.sanchez.2013.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanchez</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dury</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biondi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Fatimy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kothary</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbonnier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khandjian</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cote</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A novel function for the survival motorneuron protein as a translational regulator.</article-title>
                <source>Hum mol Genet</source>
                <volume>22</volume>
                <fpage>668</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">23136128</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.scarciolla.2006.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scarciolla</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuppia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Angelis</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murru</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palka</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pace</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Muzio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torrente</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grammatico</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacanelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosatelli</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uncini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification.</article-title>
                <source>Neurogenetics.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">16865356</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.solerbotija.2005.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soler-Botija</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cusco</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caselles</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiget</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tizzano</surname>
                    <given-names>EF</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>64</volume>
                <fpage>215</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15804053</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.sporer.2003.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sporer</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Hip dislocation in patients with spinal muscular atrophy.</article-title>
                <source>J Pediatr Orthop</source>
                <volume>23</volume>
                <fpage>10</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12499935</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.strasswimmer.1999.1219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strasswimmer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorson</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breiding</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Androphy</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of survival motor neuron as a transcriptional activator-binding protein.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>1219</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">10369867</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.sugarman.2012.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugarman</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akmaev</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohlfs</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flynn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickson</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirko-Osadsa</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allitto</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <article-title>Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of &#x0003e;72,400 specimens.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2012</year>
                <volume>20</volume>
                <fpage>27</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21811307</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.sumner.2003.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sumner</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perhac</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coovert</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schussler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarecki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Valproic acid increases SMN levels in spinal muscular atrophy patient cells.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>647</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">14595654</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.swoboda.2005.704">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNaught</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wride</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reyna</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromberg</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Natural history of denervation in SMA: relation to age, SMN2 copy number, and function.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>704</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">15852397</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.swoboda.2010.1605">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <article-title>Seize the day: Newborn screening for SMA.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>1605</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20583173</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.talbot.1997.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponting</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodosiou</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodrigues</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mountford</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>KE</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>497</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">9147655</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.thieme.1993.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thieme</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitulla</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegler</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thuringen).</article-title>
                <source>Hum Genet</source>
                <volume>91</volume>
                <fpage>295</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8478016</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.vyas.2002.2751">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vyas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bechade</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riveau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downward</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triller</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Involvement of survival motor neuron (SMN) protein in cell death.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2751</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12374765</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.wang.2007.1027">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkel</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonds</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aloysius</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trela</surname>
                    <given-names>A</given-names>
                  </name>
                  <collab>Participants of the International Conference on SMA Standard of Care</collab>
                </person-group>
                <year>2007</year>
                <article-title>Consensus statement for standard of care in spinal muscular atrophy.</article-title>
                <source>J Child Neurol</source>
                <volume>22</volume>
                <fpage>1027</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">17761659</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.werdnig.1971.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Werdnig</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891.</article-title>
                <source>Arch Neurol.</source>
                <year>1971</year>
                <volume>25</volume>
                <fpage>276</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">4952838</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.wirth.2000.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy.</article-title>
                <source>Hum Mutat</source>
                <volume>15</volume>
                <fpage>228</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">10679938</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.wirth.1997.1102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawczak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller-Myhsok</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schonling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>1102</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9345102</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.workman.2012.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Workman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolb</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battle</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy.</article-title>
                <source>Brain Res.</source>
                <year>2012</year>
                <volume>1462</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22424789</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.yamashita.2004.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishio</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Significant increase in the number of the SMN2 gene copies in an adult-onset Type III spinal muscular atrophy patient with homozygous deletion of the NAIP gene.</article-title>
                <source>Eur Neurol</source>
                <volume>52</volume>
                <fpage>101</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15305106</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.yohannan.1991.426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yohannan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolawole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malabarey</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahdi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Brain atrophy in Werdnig-Hoffmann disease.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>84</volume>
                <fpage>426</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1776391</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.zerres.1997.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lusakowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borkowska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.</article-title>
                <source>J Neurol Sci</source>
                <volume>146</volume>
                <fpage>67</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">9077498</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.zheleznyakova.2011.96">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zheleznyakova</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiselev</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vakharlovsky</surname>
                    <given-names>VG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rask-Anderson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chavan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egorova</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schioth</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baranov</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III.</article-title>
                <source>BMC Med Genet</source>
                <volume>12</volume>
                <fpage>96</fpage>
                <pub-id pub-id-type="pmid">21762474</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sma.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="sma.Suggested_Reading.reflist0">
            <ref id="sma.REF.bove.1988.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Atypical infantile spinomuscular atrophy presenting as acute diaphragmatic paralysis.</article-title>
                <source>Pediatr Pathol.</source>
                <volume>8</volume>
                <fpage>95</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">3399458</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.bromberg.2002.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bromberg</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Motor unit number estimation in infants and children with spinal muscular atrophy.</article-title>
                <source>Muscle Nerve.</source>
                <volume>25</volume>
                <fpage>445</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11870724</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.burghes.1997.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burghes</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>When is a deletion not a deletion? When it is converted.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>61</volume>
                <fpage>9</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">9245977</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.escolar.2001.787">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escolar</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henricson</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayhew</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florence</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemens</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.</article-title>
                <source>Muscle Nerve</source>
                <volume>24</volume>
                <fpage>787</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11360262</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.kaufmann.2007.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <collab>International Coordinating Committee for SMA Subcommittee on SMA Clinical Trial Design</collab>
                </person-group>
                <year>2007</year>
                <article-title>Issues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>17</volume>
                <fpage>499</fpage>
                <lpage>505</lpage>
                <pub-id pub-id-type="pmid">17300938</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.lunn.2008.2120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lunn</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Spinal muscular atrophy.</article-title>
                <source>Lancet.</source>
                <volume>371</volume>
                <fpage>2120</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">18572081</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.main.2003.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kairon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>7</volume>
                <fpage>155</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12865054</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.nelson.2006.374">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owens</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hynan</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <article-title>AmSMART Group. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2006</year>
                <volume>16</volume>
                <fpage>374</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16632361</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.vital.1989.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coquet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandorena</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demarquez</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Congenital hypomyelination with axonopathy.</article-title>
                <source>Eur J Pediatr</source>
                <volume>148</volume>
                <fpage>470</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">2920756</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.wirth.1995.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrig</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Prenatal prediction in families with autosomal recessive proximal spinal muscular atrophy (5q11.2-q13.3): molecular genetics and clinical experience in 109 cases.</article-title>
                <source>Prenat Diagn</source>
                <volume>15</volume>
                <fpage>407</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">7644431</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.zerres.1995.518">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.</article-title>
                <source>Arch Neurol</source>
                <volume>52</volume>
                <fpage>518</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">7733848</pub-id>
              </element-citation>
            </ref>
            <ref id="sma.REF.zerres.1995.1162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forkert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Genetic basis of adult-onset spinal muscular dystrophy.</article-title>
                <source>Lancet</source>
                <volume>346</volume>
                <fpage>1162</fpage>
                <pub-id pub-id-type="pmid">7475624</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sma.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sma.Revision_History">
          <title>Revision History</title>
          <p>Erika Finanger, MD (2016-present)Thomas W Prior, PhD, FACMG (2000-present)Barry S Russman, MD; Oregon Health and Science University (2000-2016)</p>
        </sec>
        <sec id="sma.Revision_History_1">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>22 December 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 November 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 January 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 April 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 July 2004 (br) Revision: Management</p>
            </list-item>
            <list-item>
              <p>17 October 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 February 2000 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 February 1999 (br) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
